Skip to main content

Day: January 8, 2021

Hvidbjerg Bank A/S opjusterer forventningerne til resultatet før skat for 2020

Hvidbjerg Bank A/S har fortsat den positive udvikling i bankens aktiviteter, efter offentliggørelsen af periodemeddelelsen for 3. kvartal 2020 den 12. november 2020.På denne baggrund opjusterer banken nu forventningerne til resultatet før skat for 2020 fra intervallet 13 – 18 mio. kr. til intervallet 17 – 19 mio. kr.Eventuelle spørgsmål kan rettes til bankdirektør Jens Odgaard på tlf. 9695 5220 eller   jo@hvidbjergbank.dk                                                Vedhæftet filHvidbjerg Bank opjusterer forventningerne

Continue reading

RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences

Glen Rock, N.J., Jan. 08, 2021 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPID) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that the Company’s senior management will participate in two virtual investor conferences in January:Biotech Showcase 2021 Digital (January 11-15, 2021): RespireRx’s corporate video presentation is available to all registered conference delegates via the Biotech Showcase digital platform.BIO Partnering at JPM 2021 Digital (January 11-15, 2021): RespireRX’s company profile is available to all registered conference delegates via the JPM BIO One-on-One Partnering platform.         Our corporate presentation is available on our website...

Continue reading

Royalty Pharma Announces 13% Dividend Increase

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2021 of $0.17 per class A share, reflecting a 13% increase in the company’s quarterly dividend over the previous quarter’s dividend.The dividend will be paid on March 15, 2021, to shareholders of record at the close of business on February 19, 2021.About Royalty PharmaFounded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties...

Continue reading

Medigus Enters the Wireless Charging Market for Electric Vehicle with New Autonomous Technology

Medigus entered an agreement to acquire IP and know-how including a provisional patent submitted in the USA for electric vehicles’ wireless robotic charging padOMER, Israel, Jan. 08, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS) (TASE: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, announced today the expansion of its electric vehicle operations with a purchase agreement for the IP and know-how including a provisional patent for a robotic charging pad for wireless charging of electric vehicles.The new technology is a wireless charging system platform that can automatically self-align itself with a vehicle that requires electric charging. The state-of-the-art autonomous Wireless Power Transfer (WPT) technology will seamlessly and efficiently charge the vehicle...

Continue reading

Acacia Communications Terminates Merger Agreement

MAYNARD, Mass., Jan. 08, 2021 (GLOBE NEWSWIRE) — Acacia Communications, Inc. (Nasdaq: ACIA) today announced that it has elected to terminate its merger agreement with Cisco Systems, Inc., effective immediately. The proposed merger, announced in July 2019, was conditioned on the satisfaction or waiver of customary closing conditions, including obtaining necessary regulatory approvals within the timeframe contemplated by the merger agreement. Because approval of the Chinese government’s State Administration for Market Regulation was not received within the timeframe contemplated by the merger agreement, Acacia did not have an obligation to close the merger before the arrival of the January 8, 2021 extended end date. As such, Acacia exercised its right to terminate the proposed transaction in accordance with the terms of the merger...

Continue reading

Osisko Development Closes Additional CDN $68.6 Million Non-Brokered Private Placement of Units

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTRÉAL, Jan. 08, 2021 (GLOBE NEWSWIRE) — Osisko Development Corp. (“Osisko Development” or the “Corporation“) (ODV: TSX-V) is pleased to announce the successful completion of its previously-announced non-brokered private placement of 9,346,464 units of Osisko Development (the “Units“) at a price of CDN$7.50 per Unit (or the U.S. dollar equivalent of US$5.75 per Unit) for aggregate gross proceeds of approximately CDN$68.6 million (the “Offering“). Each Unit consists of one common share of the Corporation and one-half of one common share purchase warrant of the Corporation (the “Warrant“), with each whole Warrant entitling the holder thereof to acquire one common share of the Corporation...

Continue reading

Capstone Infrastructure Corporation Announces the Acquisition of a Portfolio of Wind Projects in Ontario

TORONTO, Jan. 08, 2021 (GLOBE NEWSWIRE) — Capstone Infrastructure Corporation (TSX: CSE.PR.A) (the “Corporation” or “Capstone”) is pleased to announce its acquisition of 29 MW of operating wind projects, known as the Springwood, Whittington, Napier and Sumac Ridge wind facilities from wpd Europe GmbH (“wpd”).Capstone acquired the projects with a combination of equity and non-recourse project debt with MUFG Bank, Ltd., Canada Branch and Associated Bank, N.A. The four facilities average 14 years remaining on their power purchase agreements and will be operated and maintained by Capstone’s in-house operations and maintenance team.“These projects are an excellent addition to Capstone’s portfolio, with long-life contracts, located in close proximity to several of our existing wind farms which utilize the same...

Continue reading

Ceapro Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference

EDMONTON, Alberta, Jan. 08, 2021 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that Gilles Gagnon, President and Chief Executive Officer of Ceapro will present at the H.C. Wainwright BioConnect 2021 Virtual Conference taking place January 11-14, 2021.The video webcast presentation will be available for viewing on-demand beginning Monday, January 11, 2021, at 6:00 AM ET for those registered for the event and will be accessible on the IR Calendar page of the Investors section of the Company’s website (www.ceapro.com) and will be archived for 90 days following the event.For more information about the event, please visit the...

Continue reading

ABM Industries to Participate in the Sidoti Virtual Investor Conference

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, announced today that the Company will participate in the Sidoti Virtual Investor Conference on Wednesday, January 13, 2021.The Company’s discussion is scheduled to begin at 1:00 p.m. (ET) on Wednesday, January 13, 2021. A live audio webcast of the presentation may be accessed at the ‘Investors’ section of the Company’s website, located at www.abm.com. An archive will also be available on the ABM website for 90 days.ABOUT ABMABM (NYSE: ABM) is a leading provider of facility solutions with revenues of approximately $6.0 billion and more than 100,000 employees in 350+ offices throughout the United States and various international locations. ABM’s comprehensive capabilities include janitorial, electrical & lighting, energy...

Continue reading

Hurco Reports Fourth Quarter and Full Year Results for Fiscal 2020

INDIANAPOLIS, Jan. 08, 2021 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the fourth fiscal quarter and fiscal year ended October 31, 2020. Hurco recorded a net loss of $3,589,000, or $(0.54) per diluted share, for the fourth quarter of fiscal 2020, compared to net income of $2,098,000, or $0.31 per diluted share, for the corresponding period in fiscal 2019. For fiscal 2020, Hurco reported a net loss of $6,247,000, or $(0.93) per diluted share, compared to net income of $17,495,000, or $2.55 per diluted share, for fiscal 2019. The net loss for the fourth quarter and fiscal 2020 included a one-time, non-cash goodwill impairment charge of $4,903,000. Excluding the impact of this one-time charge, earnings per diluted share would have been $0.70 and $0.69 higher than what was reported for the fourth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.